partially supported by a research grant from Sumitomo Marine Welfare Foundation, a research grant from Nis- san Science Foundation, and a Grant-in Aid for Scientiﬁc Research for the Ministry of Education, Culture, Sports, Science and Technology of Japan. Abbreviations AβP, β-amyloid protein; AD, Alzheimer’s disease; DHEA, dehydroepiandrosterone; DHEA-S, dehydroepiandrosterone sulfate; DIV, days in vitro; [Ca2+] , intracellular calcium level; i [N-methyl-D-aspartate], NMDA. References Arispe N, Rojas E, Pollard HB. 1993a. Alzheimer disease amyloid β protein forms calcium channels in bilayer membranes: Blockade by trometh- amine and aluminum. Proc Natl Acad Sci USA, 90:567–71. Arispe N, Rojas E, Pollard HB. 1993b. Giant multilevel cation channels formed by Alzheimer disease amyloid β protein [AβP-(1–40)] in bilayer membranes. Proc Natl Acad Sci USA, 90:10573–7. Arispe N, Pollard HB, Rojas E. 1996. Zn2+ interactions with Alzheimer’s amyloid β protein calcium channels. Proc Natl Acad Sci USA, 93:1710–5. Banker GA, Cowan WM. 1977. Rat hippocampal neurons in dispersed cell culture. Brain Res, 126:397–42. Bechinger B. 1997. Structure and functions of channel-forming peptides: Magainins, cecropins, melittin and alamethicin. J Membr Biol, 156:197–211. Charalampopoulos I, Alexaki VI, Tsatsanis C, et al. 2006. Neurosteroids as endogenous inhibitors of neuronal cell apoptosis in aging. Ann N Y Acad Sci, 1088:139–52. Corder EH, Saunders AM, Strittmatter WJ, et al. 1993. Gene dose of apo- lipoprotein E type 4 allele and the risk of Alzheimer‘s disease in late onset families. Science, 261:921–3. Fraser SP, Suh YH, Chong YH, et al. 1996. Membrane currents induced in Xenopus oocytes by the C-terminal fragment of the β-amyloid precursor protein. J Neurochem, 66:2034–40. Fraser SP, Suh YH, Djamgoz MB. 1997. Ionic effects of the Alzheimer’s disease β-amyloid precursor protein and its metabolic fragments. Trends Neurosci, 20:67–72. Frears ER, Stephens DJ, Walters CE, et al. 1999. The role of cholesterol in the biosynthesis of beta-amyloid. Neuroreport, 10:1699–705. Fujii G, Chang JE, Coley T, et al. 1997. The formation of amphotericin B ion channels in lipid bilayers. Biochemistry, 36:4959–68. Furukawa K, Abe Y, Akaike N. 1994. Amyloid β protein-induced irrevers- ible current in rat cortical neurons. Neuroreport, 5:2016–8. Goate A, Chartier-Harlin MC, Mullan M, et al. 1991. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer’s disease. Nature, 349:704–6. Hartley DM, Walsh DM, Ye CP, et al. 1999. Protoﬁbrillar intermediates of amyloid β-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons. J Neurosci, 19:8876–84. Hartmann H, Eckert A, Muller WE. 1994. Apolipoprotein E and cho- lesterol affect neuronal calcium signalling: the possible relationship to beta-amyloid neurotoxicity. Biochem Biophys Res Commun, 200:1185–92. Hartmann T. 2001. Cholesterol, Aβ, and Alzheimer’s disease. Trends Neurosci, 24:S45–S49. Hertel C, Terzi E, Hauser N, et al. 1997. Inhibition of the electro- static interaction between beta-amyloid peptide and membranes prevents beta-amyloid-induced toxicity. Proc Natl Acad Sci USA, 94:9412–6. Neuropsychiatric Disease and Treatment 2008:4(1) Neurosteroids block AβP neurotoxicity Hillen T, Lun A, Reischies FM, et al. 2000. DHEA-S plasma levels and incidence of Alzheimer‘s disease. Biol. Psychiatry, 47:161–3. Hirakura Y, Lin MC, Kagan BL. 1999. Alzheimer amyloid Aβ1–42 channels: effects of solvent, pH, and Congo Red. J Neurosci Res, 57:458–66. Huppert FA, Van Niekerk JK, Herbert J. 2000. Dehydroepiandrosterone (DHEA) supplementation for cognition and well-being. Cochrane Database Syst Rev, 2:CD000304. Kato-Negishia M, Muramoto K, Kawahara M. et al. 2004. Developmental changes of GABAergic synapses formed between primary cultured cortical neurons, Brain Res Dev Brain Res, 152:99–108. Kawahara M, Arispe N, Kuroda Y, et al. 1997. Alzheimer's disease amyloid β-protein forms Zn2+-sensitive, cation-selective channels across excised membrane patches from hypothalamic neurons. Biophys J, 73:67–75. Kawahara M, Arispe N, Kuroda Y, et al. 2000. Alzheimer’s β-amyloid, human islet amylin and prion protein fragment evoke intracellular free-calcium elevations by a common mechanism in a hypothalamic GnRH neuronal cell-line. J Biol Chem, 275:14077–83. Kawahara M, Kuroda Y. 2000. Molecular mechanism of neurodegeneration induced by Alzheimer’s β-amyloid protein: channel formation and disruption of calcium homeostasis. Brain Res Bull, 53:389–97. Kawahara M, Kuroda Y. 2001. Intracellular calcium changes in neuronal cells induced by Alzheimer’s β-amyloid protein are blocked by estradiol and cholesterol, Cell Mol Neurobiol, 21:1–13. Kawahara M. 2004. Disruption of calcium homeostasis in Alzheimer’s disease and other conformational diseases, Current Alzheimer Research, 1:87–95. Kimonides VG, Khatibi NH, Svendsen CN, et al. 1998. Dehydroepiandros- terone (DHEA) and DHEA-sulfate (DHEAS) protect hippocampal neurons against excitatory amino acid-induced neurotoxicity. Proc Natl Acad Sci USA, 95:1852–7. Kobayashi S, Chikushi A, Tougu S, et al. 2004. Membrane translocation mechanism of the antimicrobial peptide buforin 2. Biochemistry, 43:15610–6. Kudo Y, Ogura A. 1986. Glutamate-induced increase in intracellular Ca2+ concentration in isolated hippocampal neurons. Br J Pharmacol, 89:191–8. Marx CE, Trost WT, Shampine LJ, et al. 2006. The neurosteroid allopreg- nanolone is reduced in prefrontal cortex in Alzheimer’s disease. Biol Psychiatry, 60:1287–94. Mattson MP, Cheng B, Davis D, et al. 1992. β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J Neurosci, 12:376–89. Meyer JH, Lee S, Wittenberg GF, et al. 1999. Neurosteroid regulation of inhibitory synaptic transmission in the rat hippocampus in vitro. Neuroscience, 90:1177–83. Mirzabekov T, Lin MC, Yuan WL, et al. 1994. Channel formation in pla- nar lipid bilayers by a neurotoxic fragment of the β-amyloid peptide. Biochem Biophys Res Commun, 202:1142–8. Moffat SD, Zonderman AB, Harman SM, et al. 2000. The relationship between longitudinal declines in dehydroepiandrosterone sulfate concentrations and cognitive performance in older men. Arch Intern Med, 160:2193–8. Muramoto K, Ichikawa M, Kawahara M, et al. 1993. Frequency of synchro- nous oscillations of neuronal activity increases during development and is correlated to the number of synapses in cultured cortical neuron networks. Neurosci Lett, 163:163–5. Olivieri G, Novakovic M, Savaskan E, et al. 2002. The effects of beta- estradiol on SHSY5Y neuroblastoma cells during heavy metal induced oxidative stress, neurotoxicity and beta-amyloid secretion. Neuroscience, 113:849–55. Pike CJ, Cotman CW. 1993. Cultured GABA-immunoreactive neurons are resistant to toxicity induced by β-amyloid. Neuroscience, 56:269–74. Pollard HB, Arispe N, Rojas E. 1995. Ion channel hypothesis for Alzheimer amyloid peptide neurotoxicity. Cell Mol Neurobiol, 15:513–26. RheeSK,QuistAP,LalR.1998.Amyloidβprotein-(1–42)formscalcium-permeable, Zn2+-sensitive channel. J Biol Chem, 273:13379–82. 217